Significance of neutrophil to lymphocyte ratio as a predictor of outcome in head and neck cancer treated with definitive chemoradiation

被引:5
|
作者
Kazmierska, Joanna [1 ,2 ,4 ]
Bajon, Tomasz [1 ]
Winiecki, Tomasz [1 ]
Borowczak, Dominika [1 ]
Bandurska-Luque, Anna [1 ]
Jankowska, Malgorzata [1 ]
Zmijewska-Tomczak, Malgorzata [3 ]
机构
[1] Greater Poland Canc Ctr, Radiotherapy Dept 2, Poznan, Poland
[2] Univ Med Sci, Electroradiol Dept, Poznan, Poland
[3] Greater Poland Canc Ctr, Radiotherapy Dept 1, Poznan, Poland
[4] Greater Poland Canc Ctr, Radiotherapy & Oncol, Garbary 15, PL-61866 Poznan, Poland
关键词
neutrophil-to-lymphocyte ratio; head and neck cancer; prediction; MICROENVIRONMENT; CHEMOTHERAPY; RADIOTHERAPY; MECHANISMS; SURVIVAL; NLR;
D O I
10.5603/RPOR.a2023.0042
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background:The role of host immune system in carcinogenesis and response to treatment is increasingly studied, including predictive potential of circulating neutrophils and lymphocytes. The objective of the study was to evaluate the prognostic val-ue of pre-and post-treatment neutrophil-to-lymphocyte (NLR) for treatment outcome in patients diagnosed with squamous cell carcinoma of head and neck (HNSCC) treated with definitive chemoradiation. Materials and methods: Electronic medical records of patients were evaluated and NLR was calculated. Cox regression was used to assess the impact of selected variables on overall survival (OS), disease specific survival (DSS), progression free sur-vival (PFS) and distant failure free survival (DFFS). Logistic regression was used to estimate odds ratios of complete response with NLR. Results: 317 patients' records were included in the study. Increases in both pre-and post-NLR were associated with decreased OS in univariable analysis [hazard ratio (HR): 2.26 (1.25-4.07), p = 0.0068 and HR: 1.57 (1.03-2.37), p = 0.035 respectively). Post-NLR remained significant for OS in multivariable analysis [HR: 1.93 (1.22-3.1), p = 0.005] as well as for unfavorable DSS [HR: 2.31 (1.22-4.4), p = 0.01]. Pre-treatment NLR and nodal status correlated with shorter DFFS in multivariable analysis [HR 4.1 (1.14-14), p = 0.03 and HR 5.3: (1.62-18), p = 0.0062, respectively]. Strong correlation of increased both pre-and post-NLR with probability of clinical tumor response (CR) was found [odds ratio (OR): 0.23 (0.08-0.6), p = 0.003, and OR: 0.39 (0.2-0.8), p = 0.01 respectively]. Conclusion: NLR evaluated before and post treatment was a strong predictor of unfavorable treatment outcome and can be used for risk evaluation and clinical decision about treatment and post-treatment surveillance.
引用
收藏
页码:389 / 398
页数:10
相关论文
共 50 条
  • [21] The ratio of neutrophil to lymphocyte is a predictor in endometrial cancer
    Dong, Yangyang
    Cheng, Yuan
    Wang, Jianliu
    OPEN LIFE SCIENCES, 2019, 14 (01): : 110 - 118
  • [22] Blood Neutrophil-to-Lymphocyte Ratio as a Predictor of Response to Chemotherapy in Head-and-Neck Cancers
    Hashemi-Bahremani, Mohammad
    Mortazavi, Nafiseh
    Novin, Kambiz
    Ameri, Ahmad
    Razzaghi, Zahra
    JOURNAL OF HEAD & NECK PHYSICIANS AND SURGEONS, 2019, 7 (01): : 20 - 25
  • [23] The prognostic value of derived neutrophil to lymphocyte ratio in oesophageal cancer treated with definitive chemoradiotherapy
    Cox, Samantha
    Hurt, Christopher
    Grenader, Tal
    Mukherjee, Somnath
    Bridgewater, John
    Crosby, Thomas
    RADIOTHERAPY AND ONCOLOGY, 2017, 125 (01) : 154 - 159
  • [24] High neutrophil-to-lymphocyte ratio predicts poor prognosis in patients with squamous cell carcinoma of the head and neck treated with definitive chemoradiotherapy
    Chandrasekara, Sahan
    Davis, Sidney
    Thomson, Peter
    Haydon, Andrew
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2018, 14 (05) : e442 - e447
  • [25] Prognostic significance of initial hemoglobin in head and neck cancer treated by primary chemoradiation
    Dietz, A
    Rudat, V
    Conradt, C
    Vanselow, B
    Wollensack, P
    Staar, S
    Eckel, H
    Volling, P
    Schröder, M
    Wannenmacher, M
    Müller, RP
    Weidauer, H
    HNO, 2000, 48 (09) : 655 - 664
  • [26] Neutrophil-to-lymphocyte ratio (NLR) and survival in recurrent or metastatic head and neck cancer patients treated with immunotherapy
    Franco, A.
    Tresch, E.
    Sakji, I.
    Makhloufi, S.
    Abdeddaim, C.
    Julieron, M.
    Dansin, E.
    Chevalier, D.
    Mouawad, F.
    Lefebvre, G.
    ANNALS OF ONCOLOGY, 2020, 31 : S676 - S676
  • [27] Pretreatment neutrophil-lymphocyte ratio as a prognostic factor in recurrent/metastatic head and neck cancer treated with pembrolizumab
    Kasahara, Yuki
    Saijo, Ken
    Ueta, Reio
    Numakura, Ryunosuke
    Sasaki, Keiju
    Yoshida, Yuya
    Taniguchi, Sakura
    Ouchi, Kota
    Komine, Keigo
    Imai, Hiroo
    Shirota, Hidekazu
    Takahashi, Masanobu
    Ishioka, Chikashi
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [28] Prognosis and Neutrophil-to-Lymphocyte Ratio in Nivolumab-treated Patients with Recurrent/Metastatic Head and Neck Cancer
    Ota, I.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 106 (05): : 1174 - 1174
  • [29] Association of absolute neutrophil count with outcomes in patients with head and neck cancer treated with chemoradiation
    Gill, Jasmin
    Virk, Jas
    Fekrmandi, Fatemeh
    Iovoli, Austin
    Farrugia, Mark
    Ma, Sung Jun
    Singh, Anurag K.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [30] Timing of radiotherapy and chemotherapy start for patients treated with definitive concurrent chemoradiation for head and neck cancer
    Steber, Cole R.
    Russell, Gregory B.
    Rush, Marie C.
    Shenker, Rachel F.
    Frizzell, Bart A.
    Greven, Kathryn M.
    Hughes, Ryan T.
    ACTA ONCOLOGICA, 2022, 61 (08) : 987 - 993